Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |